Janux Therapeutics (JANX) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Janux Therapeutics (JANX) over the last 6 years, with Q3 2025 value amounting to -$8.1 million.
- Janux Therapeutics' Other Gross PP&E Adjustments rose 1783.18% to -$8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.1 million, marking a year-over-year increase of 1783.18%. This contributed to the annual value of -$13.2 million for FY2024, which is 1168.43% up from last year.
- Latest data reveals that Janux Therapeutics reported Other Gross PP&E Adjustments of -$8.1 million as of Q3 2025, which was up 1783.18% from -$7.8 million recorded in Q2 2025.
- Over the past 5 years, Janux Therapeutics' Other Gross PP&E Adjustments peaked at $2.7 million during Q1 2022, and registered a low of -$18.9 million during Q2 2022.
- In the last 5 years, Janux Therapeutics' Other Gross PP&E Adjustments had a median value of -$10.4 million in 2024 and averaged -$9.4 million.
- Per our database at Business Quant, Janux Therapeutics' Other Gross PP&E Adjustments plummeted by 2089294.12% in 2022 and then soared by 3494.69% in 2023.
- Over the past 5 years, Janux Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $85000.0 in 2021, then crashed by 20892.94% to -$17.7 million in 2022, then increased by 15.55% to -$14.9 million in 2023, then grew by 11.68% to -$13.2 million in 2024, then soared by 38.48% to -$8.1 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$8.1 million for Q3 2025, versus -$7.8 million for Q2 2025 and -$8.5 million for Q1 2025.